2024 Annual Meeting | N5 - Neuroscience in the Clinic: Exploring the Gut-brain Axis

Date Wednesday 04/17/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | Bluebird 1B

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Roneil Malkani, MD, Howard L. Weiner, MD

Topic(s) General Neurology, Movement Disorders, Epilepsy/Clinical Neurophysiology (EEG), Epilepsy/Clinical Neurophysiology (EEG), Movement Disorders

Learning Objectives Participants should be able to describe the relationships between the gut microbiome on the pathophysiology and function in neurologic diseases, including multiple sclerosis, autism, and neurodegenerative disorders such as Alzheimer’s disease and Parkinson's disease.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM MDT	Introduction	Introduction Roneil Malkani, MD
03:35 PM - 03:45 PM MDT	Speaker	Case Presentation Juan R. Deliz Gonzalez, MD
03:45 PM - 04:10 PM MDT	Speaker	Microbiome Immune Interactions in Multiple Sclerosis and Alzheimer's Disease Laura M. Cox
04:10 PM - 04:35 PM MDT	Speaker	Contributions of the Gut Microbiome to Parkinson's Disease Pathologies Tim Sampson
04:35 PM - 04:45 PM MDT	Abstract	001 - Effects of a four-strain probiotic on inflammatory markers in Parkinson's disease: a multicentre randomised controlled trial (the SymPD study) Valentina Leta
04:45 PM - 05:10 PM MDT	Speaker	Improving the Microbiome to Manage Autism Spectrum Disorder Symptoms Rosa Krajmalnik-Brown
05:10 PM - 05:20 PM MDT	Abstract	002 - Shotgun Metagenomic Analysis to Study the Role of Gut Dysbiosis in Drug-Resistant Epilepsy William C. Leung, MBBS, MRCP, FHKAM
05:20 PM - 05:25 PM MDT	Speaker	Case Follow-up
05:25 PM - 05:30 PM MDT	Q&A	Wrap-up and Q&A Roneil Malkani, MD, Howard L. Weiner, MD, Laura M. Cox, Rosa Krajmalnik-Brown, Tim Sampson

Faculty Disclosures
Roneil Malkani, MD	The institution of Dr. Malkani has received research support from NIH. The institution of Dr. Malkani has received research support from Northwestern University. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with American Academy of Neurology. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $0-$499 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has a non-compensated relationship as a Committee Member with American Academy of Sleep Medicine that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Laura M. Cox	No disclosure on file
Rosa Krajmalnik-Brown	No disclosure on file
Tim Sampson	No disclosure on file
William C. Leung, MBBS, MRCP, FHKAM	Dr. Leung has nothing to disclose.
Xueyan HU	Miss HU has nothing to disclose.
Joshua Ho	No disclosure on file
Holy Chan	No disclosure on file
Hui Ning Florinda Chu	No disclosure on file
Cheuk Nam Rachel Lo	No disclosure on file
Gary K. Lau, MBBS	Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.
Wui Hang Ho, MBBS	Dr. Ho has nothing to disclose.
Valentina Leta	No disclosure on file
Gargi Mandal	No disclosure on file
Pavlos Zinzalias	No disclosure on file
Juliet Staunton	No disclosure on file
Lucia Batzu	No disclosure on file
Dhaval Trivedi	No disclosure on file
Kristina Rosqvist	No disclosure on file
Jonathan Timpka	No disclosure on file
Trinette Van Vliet	No disclosure on file
Aleksandra Podlewska, PhD	Miss Podlewska has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bial . The institution of Miss Podlewska has received research support from Wellcome Trust.
Miriam Parry	No disclosure on file
Daniel van Wamelen	No disclosure on file
Alexandra Rizos	No disclosure on file
Guy Chung-Faye	No disclosure on file
Per Odin	No disclosure on file
Carmine Pariante	No disclosure on file
Alessandra Borsini	No disclosure on file
Kallol R. Chaudhuri, MD, FRCP	Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Juan R. Deliz Gonzalez, MD	Dr. Deliz Gonzalez has nothing to disclose.